Psoriasis flare-ups following sorafenib therapy: A rare case

Ming Chun Hsu, Chih Chiang Chen*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

5 Scopus citations


Sorafenib is a multikinase inhibitor that blocks tumor cell proliferation and angiogenesis. While adverse skin reactions occur in 90% of patients treated with angiogenesis inhibitors, only a few cases of psoriasiform eruption associated with sorafenib therapy have been reported. We report a rare case of sorafenib-related psoriasis that responded well to topical treatment and narrow-band UV-B phototherapy after discontinuation of sorafenib.

Original languageEnglish
Pages (from-to)148-150
Number of pages3
JournalDermatologica Sinica
Issue number3
StatePublished - 1 Sep 2016


  • kinase inhibitor
  • psoriasiform eruption
  • psoriasis
  • sorafenib


Dive into the research topics of 'Psoriasis flare-ups following sorafenib therapy: A rare case'. Together they form a unique fingerprint.

Cite this